Next Generation Sequencing Market is expected to grow at a CAGR of 20% to 22% from 2021 to 2026 – An exclusive market research report by Lucintel

Next Generation Sequencing Market is expected to grow at a CAGR of 20% to 22% from 2021 to 2026 - An exclusive market research report by Lucintel
Trends and Forecast for the Global Next Generation Sequencing Market
Trends, opportunities and forecast in next generation sequencing market to 2026 by product & service (presequencing products & services, NGS consumables, NGS platforms, services for NGS platforms, sequencing services, and bioinformatics), technology (sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing, and other sequencing technologies), application (diagnostics, drug discovery, agriculture & animal research), end user, and region

Lucintel’s latest market report analyzed that next generation sequencing provides attractive opportunities in academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. The next generation sequencing market is expected to grow at a CAGR of 20% to 22%. In this market, diagnostic is the largest segment by application, whereas academic institutes & research centers is largest by end use industry.

Download Brochure of this report by clicking on https://www.lucintel.com/next-generation-sequencing-market.aspx Based on application, the next generation sequencing market is segmented into diagnostics, drug discovery, agriculture & animal research, and other applications. The diagnostic segment accounted for the largest share of the market in 2020 and is expected to register the highest CAGR during the forecast period, due to rising number of cancer cases across the world.        

Browse in-depth TOC on “Next Generation Sequencing Market”

XX – Tables

XX – Figures

150 – Pages

The Next Generation Sequencing Market is marked by the presence of several big and small players. Some of the prominent players offering next generation sequencing include Illumina, Inc., Thermo Fisher Scientific, Inc. BGI Group, PerkinElmer Inc., Macrogen, Hamilton Company, Lucigen, Oxford Nanopore Technologies, Agilent Technologies, Inc., and QIAGEN

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

Media Contact
Company Name: Lucintel
Contact Person: Brandon Fitzgerald
Email: Send Email
Phone: 303.775.0751
Address:8951 Cypress Waters Blvd., Suite 160
City: Dallas
State: TEXAS
Country: United States
Website: www.lucintel.com